EW · Categories · Coverage
EW - Analyst coverage initiated
Edwards Lifesciences Corporation (EW) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for EW
- UBS initiated coverage on Edwards Lifesciences with a new price targetUBS initiated coverage of Edwards Lifesciences with a rating of Buy and set a new price target of $110.00
- Goldman initiated coverage on Edwards Lifesciences with a new price targetGoldman initiated coverage of Edwards Lifesciences with a rating of Buy and set a new price target of $107.00
- Robert W. Baird initiated coverage on Edwards Lifesciences with a new price targetRobert W. Baird initiated coverage of Edwards Lifesciences with a rating of Outperform and set a new price target of $107.00
- UBS initiated coverage on Edwards Lifesciences with a new price targetUBS initiated coverage of Edwards Lifesciences with a rating of Neutral and set a new price target of $84.00
- Mizuho initiated coverage on Edwards Lifesciences with a new price targetMizuho initiated coverage of Edwards Lifesciences with a rating of Buy and set a new price target of $100.00
- Barclays initiated coverage on Edwards Lifesciences with a new price targetBarclays initiated coverage of Edwards Lifesciences with a rating of Overweight and set a new price target of $96.00
- Jefferies initiated coverage on Edwards Lifesciences with a new price targetJefferies initiated coverage of Edwards Lifesciences with a rating of Buy and set a new price target of $110.00
- Truist initiated coverage on Edwards Lifesciences with a new price targetTruist initiated coverage of Edwards Lifesciences with a rating of Buy and set a new price target of $145.00
- Wolfe Research initiated coverage on Edwards Lifesciences with a new price targetWolfe Research initiated coverage of Edwards Lifesciences with a rating of Outperform and set a new price target of $134.00
- RBC Capital initiated coverage on Edwards Lifesciences with a new price targetRBC Capital initiated coverage of Edwards Lifesciences with a rating of Outperform and set a new price target of $142.00
- Barclays initiated coverage on Edwards Lifesciences with a new price targetBarclays initiated coverage of Edwards Lifesciences with a rating of Overweight and set a new price target of $110.00
- Atlantic Equities initiated coverage on Edwards Lifesciences with a new price targetAtlantic Equities initiated coverage of Edwards Lifesciences with a rating of Neutral and set a new price target of $85.00